Morgan Stanley Thorne Healthtech, Inc. Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$4.57 - $10.19 $64,185 - $143,118	-14,045 Reduced 18.78%	60,740 $618,000
Q2 2023 Aug 14, 2023	BUY	$4.35 - $4.91 $132,353 - $149,391	30,426 Added 68.59%	74,785 $351,000
Q1 2023 May 15, 2023	BUY	$3.54 - $5.02 $90,386 - $128,175	25,533 Added 135.63%	44,359 $204,000
Q4 2022 Feb 14, 2023	SELL	$3.5 - $5.12 $40,082 - $58,634	-11,452 Reduced 37.82%	18,826 $68,000
Q3 2022 Nov 14, 2022	SELL	$4.31 - $6.11 $103,741 - $147,067	-24,070 Reduced 44.29%	30,278 $144,000

Q2 2022 Oct 27, 2022	BUY	$4.75 - $7.34 $200,269 - $309,469	42,162 Added 345.99%	54,348 $263,000
Q2 2022 Aug 15, 2022	BUY	$4.75 - $7.34 $200,269 - $309,469	42,162 Added 345.99%	54,348 $263,000
Q1 2022 Oct 27, 2022	SELL	$4.36 - $6.56 $183,826 - $276,582	-42,162 Reduced 77.58%	12,186 $77,000
Q1 2022 May 13, 2022	SELL	$4.36 - $6.56 $21,398 - $32,196	-4,908 Reduced 28.71%	12,186 $77,000
Q4 2021 Feb 14, 2022	BUY	$5.26 - $10.0 $89,914 - $170,940	17,094 New	17,094 $107,000

Ticker THRN
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 52,742,200
Description
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits fo...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.